Results 171 to 180 of about 385,576 (363)

Targeted STING Activation Using Modified Ultrasound‐Responsive Microbubbles Enhances Immune Checkpoint Blockade Against Melanoma

open access: yesAdvanced Science, EarlyView.
This study explores the use of ultrasound contrast agents loaded with Stimulator of Interferon Genes (STING) agonists as an approach to activate the body's immune system against cancer. Termed Microbubble‐assisted UltraSound‐guided Immunotherapy of Cancer (MUSIC), this strategy effectively inhibits tumor growth and improves survival in mouse models of ...
Sina Khorsandi   +12 more
wiley   +1 more source

Oil imports and the fall of the dollar [PDF]

open access: yes
Petroleum industry and trade ; Money ...
Douglas R. Mudd, Geoffrey E. Wood
core  

Defect Engineering in Wüstite: Unlocking Control Over Iron Morphologies in Gas‐Solid Reduction

open access: yesAdvanced Science, EarlyView.
In this paper, a direct link between the concentration of defects in wüstite (FexO) and the resultant iron microstructure is established. By integrating the muti‐point nucleation and morphological evolution of iron at defect sites, a multiscale perspective on how defect engineering in FexO modulates the morphologies of iron has been developed ...
Qinghui Wu   +5 more
wiley   +1 more source

BTUs in GDP [PDF]

open access: yes
Power resources ; Petroleum industry and ...
Michael R. Pakko
core  

Decursin‐Loaded Nanovesicles Target Macrophages Driven by the Pathological Process of Atherosclerosis

open access: yesAdvanced Science, EarlyView.
This study presents decursin, a traditional Chinese medicine monomer, that inhibits lipid accumulation and inflammation in atherosclerosis through PKCδ interaction. A novel targeted delivery system (ALD@EM) is developed to overcome decursin's short half‐life, combining antibody‐mediated targeting, LDL‐facilitated chemotaxis, and enhanced macrophage ...
Hui Chen   +13 more
wiley   +1 more source

Concentration of energy production and processing on the Gulf Coast [PDF]

open access: yes
Petroleum industry and ...
Carrie Ann Fossum   +2 more
core  

A Self‐Assembling LYTAC Mediates CTGF Degradation and Remodels Inflammatory Tumor Microenvironment for Triple‐Negative Breast Cancer Therapy

open access: yesAdvanced Science, EarlyView.
A CTGF‐LYTAC nanoplatform is developed to selectively degrade connective tissue growth factor (CTGF) in triple‐negative breast cancer (TNBC), inhibiting TGF‐β signaling and cell interactions in the tumor microenvironment (TME). This strategy effectively suppresses tumor growth and metastasis, outperforming antibody‐based therapy.
Jia‐Yi Lin   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy